Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia

AMPK is a master regulator of cellular metabolism that exerts either oncogenic or tumor suppressor activity depending on context. Here, we report that the specific AMPK agonist GSK621 selectively kills acute myeloid leukemia (AML) cells but spares normal hematopoietic progenitors. This differential...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cell reports (Cambridge) Ročník 11; číslo 9; s. 1446 - 1457
Hlavní autoři:	Sujobert, Pierre, Poulain, Laury, Paubelle, Etienne, Zylbersztejn, Florence, Grenier, Adrien, Lambert, Mireille, Townsend, Elizabeth C., Brusq, Jean-Marie, Nicodeme, Edwige, Decrooqc, Justine, Nepstad, Ina, Green, Alexa S., Mondesir, Johanna, Hospital, Marie-Anne, Jacque, Nathalie, Christodoulou, Alexandra, Desouza, Tiffany A., Hermine, Olivier, Foretz, Marc, Viollet, Benoit, Lacombe, Catherine, Mayeux, Patrick, Weinstock, David M., Moura, Ivan C., Bouscary, Didier, Tamburini, Jerome
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 09.06.2015 Elsevier
Témata:	AMP-Activated Protein Kinases - metabolism Animals Antineoplastic Agents - pharmacology Enzyme Activation - drug effects Fluorescent Antibody Technique Heterografts Humans Imidazoles - pharmacology Leukemia, Myeloid, Acute - metabolism Mechanistic Target of Rapamycin Complex 1 Mice Mice, Nude Microscopy, Electron, Transmission Multiprotein Complexes - agonists Oligonucleotide Array Sequence Analysis Polymerase Chain Reaction Pyrimidinones - pharmacology RNA Interference Signal Transduction - drug effects TOR Serine-Threonine Kinases
ISSN:	2211-1247, 2211-1247
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!